Frail

2018 – ECHNO 2018 – NBTXR3 for elderly and frail HNSCC patients

Clinical Data NBTXR3, Congress Abstracts, Head & Neck

NBTXR3 administered as a single intratumoral injection and activated by radiotherapy, is currently evaluated in a phase I clinical trial for head and neck cancer. At the 2018 Multidisciplinary Head and Neck Cancers Symposium in Scottsdale Arizona, preliminary results were presented by prof. C. Le Tourneau. […]

2018 – Multidisciplinary H&N – NBTXR3 for Head and Neck Cancer

Clinical Data NBTXR3, Congress Abstracts, Head & Neck

NBTXR3 administered as a single intratumoral injection and activated by radiotherapy, is currently evaluated in a phase I clinical trial for head and neck cancer. At the 2018 Multidisciplinary Head and Neck Cancers Symposium in Scottsdale Arizona, preliminary results were presented by prof. C. Le Tourneau. […]

1
2

By continuing to use the site, you agree to the use of cookies.En poursuivant votre navigation sur ce site, vous acceptez l’utilisation de cookies. More information.En savoir plus.